echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: How epilepsy, vascular risk factors, and cognitive function relate

    Neurology: How epilepsy, vascular risk factors, and cognitive function relate

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In large, population-based longitudinal studies, older adults with epilepsy declined cognitive abilities at an average faster
    rate than expected by their age.
    Longitudinal studies of aging that combine epilepsy determination with thorough risk factor characteristics and repeated cognitive measurements are well suited to elucidate modifiable factors
    that accelerate cognitive decline in patients with epilepsy.
    Identifying these factors can help guide the development of interventions to protect the cognitive health
    of older adults with epilepsy.

    Figure 1: Cover art of the paper

    In the general aging literature, vascular risk factors (VRFs), such as high blood pressure, diabetes, and smoking, are associated
    with the development of cognitive impairment and dementia.
    About 35% of dementia is caused
    by a combination of potentially modifiable risk factors.
    However, in older adults with epilepsy, there is a clear lack of data
    on the relationship between VRFs and cognitive processes.

    Older adults with a combination of epilepsy and another risk factor may experience more cognitive decline than expected, not only more than those with epilepsy alone or another risk factor, but even more
    than expected from the sum of the excessive declines associated with epilepsy alone and another risk factor.

    This larger-than-expected decline in cognitive ability is called an "excessive decline due to the interaction" of epilepsy and other risk factors
    .
    In the Cardiovascular Health Study (CHS), as an example of this excessive decline due to the interaction of epilepsy and another factor, the average global cognitive decline in older adults with epidemic epilepsy and apolipoprotein 4 alleles has greatly exceeded expectations
    .


    Here, Columbia University's Hyunmi Choi et al.


    The Vascular Health Study (CHS) is a population-based longitudinal cohort study of 5,888 U.


    Figure 2: Graph of the paper results

    From these models, they estimated excess average cognitive decline
    due to epilepsy's interaction with each VRF.
    The result
    .
    We observed an over-average decline in global cognitive ability (3MS) due to the interaction of epilepsy with hypertension (without the interaction, the 8-year average decline was 6.
    6 points larger than expected; 95% CI: 1.
    3, 12.
    0) and abstinence from alcohol (5.
    8 points larger than expected; 95% CI: 0.
    3, 11.
    3).

    It was also observed that due to the interaction of epilepsy with previous strokes, the average decline in information processing speed (DSST) was too large (the average 9-year decline was 18.
    1 points larger than expected; 95% CI: 7.
    6, 28.
    5), alcohol abstinence (6.
    1 points larger than expected; 95% CI: 2.
    5, 9.
    8), and elevated triglyceride levels (2.
    4 points per standard deviation than expected; 95% CI: 0.
    4, 4.
    3).


    The significance of the study is that it found that some VRFs are more strongly associated with cognitive decline in older adults in the presence of epilepsy, suggesting a need for greater attention to vascular protection to maintain brain health
    in older adults with epilepsy.




    Choi H, Elkind MSV, Longstreth WT, et al.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.